Literature DB >> 16731928

Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins.

Bruno Eschli1, Katharina Quirin, Alexander Wepf, Jacqueline Weber, Rolf Zinkernagel, Hans Hengartner.   

Abstract

The lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) consists of the transmembrane subunit GP-2 and the receptor binding subunit GP-1. Both are synthesized as one precursor protein and stay noncovalently attached after cleavage. In this study, we determined the oligomeric state of the LCMV GP and expressed it in two different conformations suitable for structural analysis. Sequence analysis of GP-2 identified a trimeric heptad repeat pattern containing an N-terminal alpha-helix. An alpha-helical peptide matching this region formed a stable oligomer as revealed by gel filtration chromatography and dynamic light scattering. In contrast, a second alpha-helical peptide corresponding to a predicted C-terminal alpha-helix within GP-2 did not oligomerize. Refolding of the complete GP-2 ectodomain revealed trimeric all-alpha complexes probably representing the six-helix bundle state that is considered a hallmark of class I viral fusion proteins. Based on these results, we generated a construct consisting of the complete uncleavable LCMV GP ectodomain fused C-terminally to the trimeric motif of fibritin. Gel filtration analysis of the secreted fusion protein identified two complexes of approximately 230 and approximately 440 kDa. Both complexes bound to a set of conformational and linear antibodies. Cross-linking confirmed the 230-kDa complex to be a trimer. The 440-kDa complexes were found to represent disulfide-linked pairs of trimers, since partial reduction converted them to a complex species migrating at 250 kDa. By electron microscopy, the 230-kDa complexes appeared as single spherical particles and showed no signs of rosette formation. Our results clearly demonstrate that the arenavirus GP is a trimer and must be considered a member of the class I viral fusion protein family.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731928      PMCID: PMC1472595          DOI: 10.1128/JVI.00008-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies.

Authors:  L J Calder; L González-Reyes; B García-Barreno; S A Wharton; J J Skehel; D C Wiley; J A Melero
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

2.  Viral persistence in vivo through selection of neutralizing antibody-escape variants.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B M Senn; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 3.  Class I and class II viral fusion protein structures reveal similar principles in membrane fusion.

Authors:  David J Schibli; Winfried Weissenhorn
Journal:  Mol Membr Biol       Date:  2004 Nov-Dec       Impact factor: 2.857

4.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor.

Authors:  Ludmilla Sissoëff; Mohamed Mousli; Patrick England; Christine Tuffereau
Journal:  J Gen Virol       Date:  2005-09       Impact factor: 3.891

6.  Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.

Authors:  Stefan Kunz; Jillian M Rojek; Motoi Kanagawa; Christina F Spiropoulou; Rita Barresi; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex.

Authors:  C Di Simone; M J Buchmeier
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

Review 8.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 9.  The many mechanisms of viral membrane fusion proteins.

Authors:  L J Earp; S E Delos; H E Park; J M White
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

Review 10.  Virus membrane-fusion proteins: more than one way to make a hairpin.

Authors:  Margaret Kielian; Félix A Rey
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

View more
  81 in total

1.  X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation.

Authors:  Sébastien Igonet; Marie-Christine Vaney; Clemens Vonrhein; Clemens Vonhrein; Gérard Bricogne; Enrico A Stura; Hans Hengartner; Bruno Eschli; Félix A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion.

Authors:  Emily L Messina; Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.

Authors:  Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Colin M Exline; Jessica Y Rathbun; Paula M Cannon
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

4.  An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.

Authors:  Joanne York; Jody D Berry; Ute Ströher; Qunnu Li; Heinz Feldmann; Min Lu; Meg Trahey; Jack H Nunberg
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 5.  Novel approaches in anti-arenaviral drug development.

Authors:  Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal:  Virology       Date:  2010-12-22       Impact factor: 3.616

6.  Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope.

Authors:  Eva Mittler; Larissa Kolesnikova; Thomas Strecker; Wolfgang Garten; Stephan Becker
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Intersubunit interactions modulate pH-induced activation of membrane fusion by the Junin virus envelope glycoprotein GPC.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

8.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 9.  Structure-function relationship of the mammarenavirus envelope glycoprotein.

Authors:  Wei Wang; Zheng Zhou; Leike Zhang; Shaobo Wang; Gengfu Xiao
Journal:  Virol Sin       Date:  2016-08-04       Impact factor: 4.327

10.  Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.

Authors:  Sundaresh Shankar; Landon R Whitby; Hedi E Casquilho-Gray; Joanne York; Dale L Boger; Jack H Nunberg
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.